Colonic epithelial cell activation and the paradoxical effects of butyrate

Carcinogenesis

Volumn 20, Issue 4, 1999, Pages 539-544

  Gibson, Peter R ^b   Rosella, Ourania ^b   Wilson, Andrew J ^b   Mariadason, John M ^b   Rickard, Kurt ^b   Byron, Keith ^b   Barkla, David H ^a  

^a MONASH UNIVERSITY   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BUTYRIC ACID; HISTONE DEACETYLASE; INTERLEUKIN 8; TRICHOSTATIN A; TUMOR NECROSIS FACTOR ALPHA; UROKINASE RECEPTOR;

ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL ISOLATION; CELL SECRETION; CELL STRAIN CACO 2; COLON CANCER; COLON MUCOSA; COMPETITIVE INHIBITION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; TUMOR CELL;

EID: 0033028423     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.4.539     Document Type: Article

References (41)

1. Cummings, J.H. (1981) Short chain fatty acids in the human colon. Gut, 22, 763-779.
2. Roediger, W.E.W. (1980) Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut, 21, 793-798.
3. Young, G.P. and Gibson, P.R. (1994) Butyrate and the colorectal cancer cell. In Binder, H.J., Cummings, J. and Soergel, K.H. (eds) Short Chain Fatty Acids. Kluwer, Lancaster, pp. 148-160.
4. Hague, A., Singh, B. and Paraskeva, C. (1997) Butyrate acts as a survival factor for colonic epithelial cells: further fuel for the in vivo versus in vitro debate. Gastroenterology, 112, 1036-1040.
5. Sealy, L. and Chalkley, R. (1978) The effect of sodium butyrate on histone modification. Cell, 14, 115-121.
6. Lallemand, F., Courilleau, D., Sabbah, M., Redeuilh, G. and Mester, J. (1996) Direct inhibition of the expression of cyclin D1 gene by sodium butyrate. Biochem. Biophys. Res. Commun., 229, 163-169.
7. McCaffrey, P.G., Newsome, D.A., Fibach, E., Yoshida, M. and Su, M.S. (1997) Induction of gamma-globulin by histone deacetylase inhibitors. Blood, 90, 2075-2083.
8. Tran, C.P. Familiari, M., Parker, L.M., Whitehead, R.H. and Giraud, A.S. (1998) Short-chain fatty acids inhibit intestinal trefoil factor gene expression in colon cancer cells. Am. J. Physiol., 275, G85-G94.
9. McIntyre, A., Young, G.P., Taranto, T., Gibson, P.R. and Ward, P. (1993) Fermentation products of dietary fiber and protection against large bowel cancer in a rat model. Gut, 34, 386-391.
10. D'Argenio, G., Cosenza, V., Delle Cave, M., Iovino, P. Della Valle, N., Lombardi, G. and Mazzacca, G. (1996) Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat model. Gastroenterology, 110, 1727-1734.
11. Medina, V., Afonso, J.T., Alverez-Arguelles, H., Hernandez, C. and Gonzalez, F. (1998) Sodium butyrate inhibits carcinoma development in a 1,2-dimethylhydrazine-induced rat colon cancer. J. Ent. Parent. Nutr., 22, 14-17.
12. Gibson, P.R., Moeller, I., Kagelari, O., Folino, M. and Young, G.P. (1991) Contrasting effects of hutyrate on expression of phenotypic markers of differentiation in neoplastic and non-neoplastic colonic epithelial cells in vitro. J. Gastro. Hepatol., 7, 165-172.
13. Velazquez, O.C., Lederer, H.M. and Rombeau, J.L. (1996) Butyrate and the colonocyte. Implications for neoplasia. Dig. Dis. Sci., 41, 727-739.
14. Jass, J.R. (1985) Diet, butyric acid and differentiation of gastrointestinal tract tumours. Med. Hypoth., 18, 113-118.
15. Yoshida, M., Kijima, M., Akita, M. and Beppu, T. (1990) Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem., 265, 17174-17179.
16. McBain, J.A., Eastman, A., Nobel, S. and Mueller, G.C. (1997) Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors. Biochem. Pharmacol., 53, 1357-1.368.
17. Singh, B., Halestrap, A.P. and Paraskeva, C. (1997) Butyrate can act as a stimulator of growth or inducer of apoptosis in human colonic epithelial cell lines depending on the presence of alternative energy sources. Carcinogenesis, 18, 1265-1270.
18. Gibson, P.R., Rosella, O. and Young, G.P. (1994) Butyrate is a potent inhibitor of urokinase secretion by normal colonic epithelium. Gastroenterology, 107, 410-419.
19. Gibson, P.R. and Rosella, O. (1996) Abnormalities of the urokinase system in colonic crypt cells from patients with ulcerative colitis. Inflamm. Bowel Dis., 2, 105-114.
20. Gibson, P.R. and Rosella, O. (1995) Interleukin-8 secretion by colonic crypt cells in vitro: a response to injury that is suppressed by butyrate and enhanced in inflammatory bowel disease. Gut, 37, 536-543.
21. Gibson, P.R., van de Pol, E., Maxwell, L., Gabriel, A. and Doe, W.F. (1989) Isolation of colonic crypts which maintain structural and metabolic viability during short term culture in vitro. Gastroenterology, 96, 283-291.
22. Janicke, E. Schmitt, M., Hafter, R., Hollrieder, A., Babic, R., Ulm, K. and Graeff, H. (1990) Urokinase-type plasminogen activator (u-PA) antigen is a predictor of early relapse in breast cancer. Fibrinolysis, 4, 69-78.
23. Ganesh, S., Sier, C.F.M., Heerding, M. M., Griffioen, G., Lamers, C.B.H.W. and Verspaget, H.W. (1994) Urokinase receptor and colorectal cancer survival. Lancet, 344, 401-402.
24. Bradford, M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-251.
25. Lazarus, G.S. and Jensen, P.J. (1991) Plasminogen activators in epithelial biology. Semin. Thromb. Hemost., 17, 210-216.
26. Andreasen, P.A., Kjoller, L., Christensen, L. and Duffy, M.J. (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer, 72, 1-22.
27. Morimoto, K., Mishima, H., Nishida, T. and Otori, T. (1993) Role of urokinase type plasminogen activator (u-PA) in corneal epithelial migration. Thromb. Haemost., 69, 387-391.
28. Gibson, P.R., Birchall, I., Rosella, O., Albert, V., Finch, C.F., Barkla, D.H. and Young, G.P. (1998) Urokinase and the intestinal mucosa: evidence for a role in epithelial cell turnover. Gut, 43, 656-663.
29. Michel, G., Kemeny, L., Peter, R.U., Beetz, A., Ried, C. Arenberger, P. and Ruzicka, T. (1992) Interleukin-8 receptor-mediated chemotaxis of normal human epidermal cells. FEBS Lett., 305, 241-243.
30. Gibson, P.R., Rosella, O., Nov, R. and Young, G.P. (1995) Colonic epithelium is diffusely abnormal in ulcerative colitis and colorectal carcinoma. Gut, 36, 857-863.
31. Mariadason, JM., Barkia, D.H. and Gibson, P.R. (1997) Effect of short-chain fatty acids on paracellular permeability in the Caco-2 model of intestinal epithelium. Am. J. Physiol., 272, G705-G712.
32. Whitehead, R.H., Young, G.P. and Bhathal, P.S. (1987) Effects of short-chain fatty acids on a new human colon carcinoma cell line (LIM1215). Gut, 27, 1457-1463.
33. Dang, J., Wang, Y. and Doe, W.F. (1995) Sodium butyrate inhibits expression of urokinase and its receptor mRNAs at both transcription and post-transcription levels in colon cancer cells. FEBS Lett., 359, 147-150.
34. Reeder, J.A., Dickinson, J.L., Chenevix-Trench, G. and Amalis, T.M. (1997) Sodium butyrate differentially modulates plasminogen activator inhibitor type-1, urokinase plasminogen activator and its receptor in a human colon carcinoma cell line. Teratog. Carcinogen. Mutagen., 13, 75-88.
35. Wilson, A.J. and Gibson, P.R. (1997) Short chain fatty acids promote the migration of colonic epithelial cells in vitro. Gastroenterology, 113, 487-496.
36. Gibson, P.R., Rosella, O., Rosella, G. and Young, G.P. (1994) Constitutive secretion by colonic epithelium of urokinase-type plasminogen activator and plasminogen activator inhibitor-1. Gut, 35, 969-975.
37. Strater, J.U., Wedding, U., Barth, T.F.E., Koretz, K., Elsing, C. and Moller, P. (1996) Rapid onset of apoptosis in vitro follows disruption of β-integrin/ matrix interactions in human colonic crypt cells. Gastroenterology, 110, 1776-1784.
38. Huang, N., Katz, J.P., Martin, D.R. and Wu, G.D. (1997) Inhibition of IL-8 gene expression in Caco-2 cells by compounds which induce histone hyperacetylation. Cytokine, 9, 27-36.
39. McBain, J.A., Eastman, A., Nobel, C.S. and Mueller, G.C. (1997) Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors. Biochem. Pharmacol., 53, 1357-1368.
40. Archer, S., Meng, S. Wu, J., Johnson, J., Tang, R. and Hodin, R. (1998) Butyrate inhibits colon carcinoma cell growth through two distinct pathways. Surgery, 124, 248-253.
41. Csorda, A. (1990) On the biological role of histone deacetylation. Biochem. J., 265, 23-38.